# Peter J. Winkle M.D., Anaheim, CA – FDA Inspections

Source: https://www.keypedia.com/companies/peter-j-winkle-md/59f4c9fd-ab2a-4f72-9d4a-95d9ab6ab35f

> Inspection records and compliance data for Peter J. Winkle M.D. in Anaheim, California. 10 FDA inspections on record, 1 Form 483, last inspected October 04, 2024.

---

## Details

- Name: Peter J. Winkle M.D.
- FEI Number: 3009200288
- Address Line 1: Cenexel Act, 2441 W La Palma Ave Ste 140
- City: Anaheim
- State: California
- Zip Code: 92801
- Country Name: United States
- Address: Cenexel Act, 2441 W La Palma Ave Ste 140, Anaheim, California 92801, United States
- Country: United States

## Related Documents

- FDA Inspection 1251470 - Peter J. Winkle M.D. - 2024-10-04 — source: FDA, date: October 4, 2024
- [FDA Inspection 1251470 - Peter J. Winkle M.D. - 2024-10-04](https://www.keypedia.com/records/fda_inspections/peter-j-winkle-md/e8eb29fb-7142-47a0-9027-31dfcd6d4c75) — classification: No Action Indicated (NAI), source: FDA, date: October 4, 2024
- [FDA Inspection 1133676 - Peter J. Winkle M.D. - 2020-11-20](https://www.keypedia.com/records/fda_inspections/peter-j-winkle-md/820b11ce-3bb9-474e-ad20-c0b3cc2278a4) — classification: No Action Indicated (NAI), source: FDA, date: November 20, 2020
- FDA Inspection 1133676 - Peter J. Winkle M.D. - 2020-11-20 — classification: No Action Indicated (NAI), source: FDA, date: November 20, 2020
- [FDA Inspection 1111920 - Peter J. Winkle M.D. - 2019-11-25](https://www.keypedia.com/records/fda_inspections/peter-j-winkle-md/37db28bd-2786-485d-83d1-402f3fa45786) — classification: No Action Indicated (NAI), source: FDA, date: November 25, 2019
- FDA Inspection 1100776 - Peter J. Winkle M.D. - 2019-08-22 — classification: No Action Indicated (NAI), source: FDA, date: August 22, 2019
- [FDA Inspection 1048939 - Peter J. Winkle M.D. - 2018-04-20](https://www.keypedia.com/records/fda_inspections/peter-j-winkle-md/4cbcaf64-b0e7-453e-a1c3-063a81fb8e3e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2018
- [FDA Inspection 959890 - Peter J. Winkle M.D. - 2016-01-14](https://www.keypedia.com/records/fda_inspections/peter-j-winkle-md/cc9deda3-a2ac-4291-b82c-046aa4da3b9e) — classification: No Action Indicated (NAI), source: FDA, date: January 14, 2016
- FDA Inspection 874659 - Peter J. Winkle M.D. - 2014-04-22 — classification: No Action Indicated (NAI), source: FDA, date: April 22, 2014
- [FDA Inspection 832561 - Peter J. Winkle M.D. - 2013-05-22](https://www.keypedia.com/records/fda_inspections/peter-j-winkle-md/d7758642-60b5-404c-84c5-819182c09e5d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 22, 2013

## Related Companies

- [Kenneth B. Deck, MD](https://www.keypedia.com/companies/kenneth-b-deck-md/9b68cdf0-15b5-4b99-b508-794940c5dec7)
- [Mary Greeley Medical Center IRB](https://www.keypedia.com/companies/mary-greeley-medical-center-irb/048877be-b21e-4414-a10f-bafd9d84ee68)
- [Columbus CCOP IRB](https://www.keypedia.com/companies/columbus-ccop-irb/94ba43a0-7e1e-4b3b-9227-66e66f379745)
- [Daniel F. Soteres, M.D.](https://www.keypedia.com/companies/daniel-f-soteres-md/219d2bde-4079-400e-a2cd-9dcd628fdbf0)
- [Steven G Hull MD](https://www.keypedia.com/companies/steven-g-hull-md/6fbbbf47-1ed7-45bc-9373-a99ba05e987b)
- [Levy, Robyn, MD](https://www.keypedia.com/companies/levy-robyn-md/04c99e5b-7894-458f-96e7-f442dd7026b5)
- [Johan A. Maertens, M.D.](https://www.keypedia.com/companies/johan-a-maertens-md/612f40da-7cf4-4401-8602-f6a8ed233195)
- [Albert Oriol Rocafiguera, MD](https://www.keypedia.com/companies/albert-oriol-rocafiguera-md/7b0e6e6b-50e3-4bc2-a857-1ef4c9c9a766)
- [Nelco Vet, LLC](https://www.keypedia.com/companies/nelco-vet-llc/b1a5a3f4-5e49-4010-9eff-c469e53816fb)
- [Mark E. Kutner, MD](https://www.keypedia.com/companies/mark-e-kutner-md/b85a53f8-1d68-4032-9262-f745c5e13e74)